592
V. N. Pathak, R. Gupta and B. Varshney
Vol 45
Phytother. Res. 2000, 14, 89; Bae, E. A.; Han, M. J.; Lee, M.; Kim, D.
H. Biol. Pharm. Bull. 2000, 23, 1122.
of water. The progress of reaction was monitored by TLC using
C6H6:EtOAc:90:10 as solvent system. After cooling to room
temperature, HCl (2 N; 25 mL) was added, the reaction was
extracted with chloroform and the product was purified by
column chromatography using silica gel (60 – 120 mesh) as
stationary phase and solvents of increasing polarity as mobile
phase. Pure flavone was obtained in benzene: pet-ether (4:1) as
yellow crystalline needles.
[11] Grassmann, J.; Hippeli, S.; Elstner, E. F. Plant. Physiol.
Biochem. 2002, 40, 471; Miura, S.; Watanabe, J.; Sano, M.; Tomita, T.;
Osawa, T.; Hara, Y.; Tomita, I. Biol. Pharm. Bull. 1995, 18, 1.
[12] Xu, H. X.; Lee, S. F. Phytother. Res. 2001, 15, 39.
Hamiltonmiller, J. M. T. Antimicrob. Agent Chemother. 1995, 39, 2375.
[13] Jain, A.; Martin, M. C.; Parveen, N.; Khan, N. U.; Parish, J.
H.; Hadi, S. M. Phytother Res. 1999, 13, 609.
[14] Shivji, G. M.; Zielinska, E.; Kondo, S.; Mukhtar, H.; Sander,
Method (iii): A mixture of n-TBAHSO4 (10 mmol, 3.39 g)
and KOH (20 mmol, 1.12 g) was grinded together in a mortar.
Then this mixture was transferred into a conical flask (100 mL).
D. N. J. Invest.
[15] Yamada, J.; Tomita, Y. Biosci. Biotech. Biochem. 1994, 58,
2197.
Dermatol. 1996, 106, 787.
o-hydroxyacetophenone/5-fluoro-2-hydroxyacetophenone
(1)
[16] Matsuo, N.; Yamada, K.; Yamashita, K.; Shoji, K.; Mori, M.;
Sugano, M. In Vitro Cell Dev. Biol. 1996, 32, 340.
[17] Han, C. Cancer Lett. 1997, 114, 153. Birt, D. F.; Hendrich,
S.; Wang, W. Pharmacol. Therap. 2001, 90, 157.
[18] Vlietnick, A. J.; Vanden Berghe, D. A.; Haemers, A. Plant
Flavonoids in Biol..And Medicine H: Biochem. Cell And Medicinal
Properties, 1988, 283.
[19] Carlo, G. Di; Mascolo, N.; Izzo, A. A; Capasso, F. Life
Sciences, 1999, 65, 337.
[20] Bovichelli, P.; Bernini, R.; Antonioletti, R.; Mincione, E.
Tetrahedron Lett. 2002, 43, 5563.
[21] Dominique, K.; Philipp, S.; Kuresh A. Y.; Zeeshan, Q.;
Catherine, R. E.; Roland, B.; Erwin, S.; Wolf-Dieter, R.; Peter R.; Peter
S. British Journal of Pharmacology 2004, 142, 811.
(10 mmol) and substituted aroyl chloride (2) (12 mmol) was
added to it and irradiated with microwaves for 5-6 minutes at
full power (800 W). Final temperature of the reaction was
measured with the help of a thermometer at the end of the
reaction. The progress of reaction was monitored by TLC using
C6H6:EtOAc: 90:10 as solvent system. After cooling to room
temperature, HCl (2 N; 25 mL) was added, the reaction was
extracted with chloroform and the product was purified by
column chromatography using silica gel (60 – 120 mesh) as
stationary phase and solvents of increasing polarity as mobile
phase. Pure pyran – 4 - ones were obtained in benzene: pet-ether
(4:1) as yellow crystalline needles.
[22] Bohm, B. A. Introduction to Flavonoids, Harwood Academic
Publishers, Amsterdam, Netherlands, 1998, pp 243.
REFERENCES
[23] (a) Wu, E. S. C.; Cole, T. E.; Davidson, T. A.; Dailey, M. A.;
Doring, K. G.; Fedorchuk, M.; Loch, J. T.; Thomas, T. L.; Blosser, J. C.;
Borrelli, A. R.; Kinsolving, C. R.; Parker, R. B.; Strand, J. C.; Watkins,
B. E. J. Med. Chem. 1989, 32, 183. (b) Ares, J. J; Outt, P. E.; Kakodkar,
S. V.; Buss, R. C.; Geiger, J.C. J. Org. Chem. 1993, 58, 7903. (c)
Zembower, D. E.; Zhang, H. ibid. 1998, 63, 9300.
*
Corresponding author. Tel.: +91 94142 55384; e-mail:
[1] Harborne, J. B.; Williams, C. A. Phytochemistry 2000, 55,
481.
[24] Jain, P. K.; Makrandi, J. K.; Grover, S. K. Synthesis 1982, 221.
[25] Makrandi, J. K.; Kumari, V. Chem. Ind. 1988, 630.
[26] (a) Nishinaga, A.; Maruyama, K.; Ando, H.; Sato, R.;
Mashino, T.; Inada, A.; Nakanishi, T.; Tetrahedron Lett. 1990, 31, 3171.
(b) Nishinaga, A.; Ando, H.; Maruyama, K.; Mashino, T. Synthesis
1992, 839.
[27] (a) Banerji, A.; Goomer, N. C. Synthesis 1980, 874. (b)
Saxena, S.; Makrandi, J.K.; Grover, S. K. ibid. 1985, 697. (c) Cushamn,
M.; Nagarathnam, D. Tetrahedron Lett. 1990, 31, 6497.
[28] (a) Nagarathnam, D.; Cushman, M. J. Org. Chem. 1991, 56,
4884. (b) Nagarathnam, D.; Cushman, M. Tetrahedron 1991, 28, 5071.
[29] Ali, S. M.; Iqbal, J.; Ilyas, M. Chem. Ind. 1985, 276.
[30] Hans, N.; Grover, S. K. Synth. Commun. 1993, 23, 1021. [31]
Litkei, G.; Gulacsi, K.; Antus, S.; Blasko, G. Liebigs Ann. 1995, 1711.
[32] Kalinin, V. N.; Shostakovsky, M. V.; Ponomaryov, A. B.
Tetrahedron Lett. 1990, 31, 4073.
[2] Middleton, E. Jr.; Kandaswami, C.; Theoharides, T. C.
Pharmacol. Rev. 2000, 52, 673.
[3] Allan, J.; Robinson, R. J. Chem. Soc. 1924, 2192.
[4] Mahal, H. S.; Venkataraman, K. Curr. Sci. 1933, 4, 214;
Mahal, H. S.; Venkataraman, K. J. Chem. Soc. 1933, 4228.
[5] Harborne, J. B. Ed. The Flavonoids Advances in research
since 1986; Chapman and Hall: New York, 1999.
[6] Chan-Bacab, M. J.; Pena-Rodriguez, L. M. Nat. Prod. Rep.
2001, 18, 674.
[7] Harborne, J. B. Nat. Prod. Rep. 1999, 16, 509.
[8] Rowley, D. C.; Hansen, M. S. T.; Rhodes, D.; Sotrier, C. A.;
Ni, H.; McCammon, J. A.; Bushmanb, F. D.; Fenicala, W. Bioorg.
Med. Chem. 2002, 10, 3619. Xu, H. X.; Wan, M.; Dong, H.; But, P. P.
H.; Foo, L. Y. Biol. Pharm. Bull. 2000, 23, 1072. Wu, J. H.; Wang, X.
H.; Yic, Y. H.; Leeb, K. H. Bioorg. Med. Chem. Lett. 2003, 13, 1813.
[9] Perez-Vizcaino, F.; Ibarra, M.; Cogolludo, A. L.; Duarte, J.;
Zaragoza-Arnaez, F.; Moreno, L.; Lopez-Lopez, G.; Tamargo, J. J.
Pharmacol. Exp. Ther. 2002, 301, 66.
[33] Makosza, M. Pure Appl. Chem. 2001, 73, 103.
[34] Lee, J. I.; Son, H. S.; Park, H. Bull. Korean Chem. Soc. 2004,
25, 1945.
[10] Sanchez, I.; Gomez-Garibay, F.; Taboada, J.; Ruiz, B. H.